While some family doctors or emergency departments will prescribe OAT to patients for free, most family doctors are hesitant ...

After adjustment for confounding variables, researchers found no increased suicide risk for GLP-1 receptor agonists versus DPP-4 inhibitors or SGLT-2 inhibitors.

Part B is testing three more doses for 12 weeks ... or as part of a combination with GLP-1/GIP agonist drugs to potentially drive greater weight loss. Novo Nordisk’s efforts to expand its ...

Samantha B. Shapiro, from the Jewish General Hospital in Montreal, and colleagues conducted an active comparator, new user cohort study to examine whether use of GLP-1 receptor agonists is ...

Sikandar's chilling story of addiction, violence, and redemption highlights the urgent need for anti-drug initiatives among ...

Use of GLP-1 receptor agonists to treat type 2 diabetes is not associated with an increased risk of suicidality compared with ...

A complaint has been filed with B.C.'s Human Rights Tribunal over clinic fees being charged to some British Columbians accessing opioid treatments.

Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases ...

Garth Mullins and the B.C. Association for People on Opioid Maintenance, have filed the complaint on behalf of those “who paid out-of-pocket private clinic access fees” for opioid agonist ...